Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MacLab is a New Zealand-based life sciences company specializing in the production of high-value bioactive ingredients derived from sustainably harvested New Zealand Greenshell Mussels (Perna canaliculus). The company operates a vertically integrated business model, controlling the process from aquaculture and harvesting to advanced extraction and stabilization of mussel-derived lipids and powders. Their products are primarily used as active ingredients in nutraceuticals and complementary medicines targeting joint health, inflammation, and mobility. MacLab is recognized for its proprietary cold-processing technology, which preserves the biological activity of the mussel's complex lipid fractions, including omega-3 fatty acids and furan fatty acids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MacLab.